Zoetis, Inc. (ZTS)
79.38
+0.96
(+1.22%)
USD |
NYSE |
Oct 16, 16:00
79.53
+0.15
(+0.19%)
After-Hours: 20:00
Zoetis Research and Development Expense (Annual) : 698.00M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 698.00M |
| December 31, 2024 | 686.00M |
| December 31, 2023 | 614.00M |
| December 31, 2022 | 539.00M |
| December 31, 2021 | 508.00M |
| December 31, 2020 | 463.00M |
| December 31, 2019 | 457.00M |
| December 31, 2018 | 432.00M |
| December 31, 2017 | 382.00M |
| Date | Value |
|---|---|
| December 31, 2016 | 376.00M |
| December 31, 2015 | 362.00M |
| December 31, 2014 | 395.00M |
| December 31, 2013 | 401.00M |
| December 31, 2012 | 400.00M |
| December 31, 2011 | 407.00M |
| December 31, 2010 | 411.00M |
| December 31, 2009 | 366.00M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Eli Lilly & Co. | 13.34B |
| Merck & Co., Inc. | 12.51B |
| Pfizer Inc. | 10.25B |
| Phibro Animal Health Corp. | 24.55M |
| Bristol Myers Squibb Co. | 9.492B |